Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study
- 1 December 2019
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 19 (12) , 1336-1344
Abstract
No abstract availableKeywords
Funding Information
- Astellas Pharma Global Development (MYCA-15L03)
- Institute of Translational Health Sciences, University of Washington (UL1 TR002345)
- Agency for Healthcare Research and Quality
- National Center for Advancing Translational Sciences (R24 HS19455)
This publication has 36 references indexed in Scilit:
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Automated Surveillance for Central Line–Associated Bloodstream Infection in Intensive Care UnitsInfection Control & Hospital Epidemiology, 2008
- Improved Clinical Outcome of Patients With Candida Bloodstream Infections Through Direct Consultation by Infectious Diseases Physicians in a Japanese University HospitalInfection Control & Hospital Epidemiology, 2006
- Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional StudyClinical Infectious Diseases, 2006
- Variable Selection for Propensity Score ModelsAmerican Journal of Epidemiology, 2006
- A meta-analysis of medical versus surgical therapy for Candida endocarditisJournal of Infection, 2005
- Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelinesDiagnostic Microbiology and Infectious Disease, 2005
- Management of Central Venous Catheters in Patients with Cancer and CandidemiaClinical Infectious Diseases, 2004
- Endogenous EndophthalmitisMedicine, 2003
- Impact of Different Measures of Comorbid Disease on Predicted Mortality of Intensive Care Unit PatientsMedical Care, 2002